My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing …in less than a minute.
BSE: 512101 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Triochem Products Ltd. a good quality company?
Data is not available for this company.
2. Is Triochem Products Ltd. undervalued or overvalued?
No data found
3. Is Triochem Products Ltd. a good buy now?
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | 11.4% | 5.3% | 8.6% | 8.9% | 8.1% | 27.5% | 8.4% | 22.4% | -2.6% | 9.6% | - | ||
| Value Creation Index ⓘ | -0.2 | -0.6 | -0.4 | -0.4 | -0.4 | 1.0 | -0.4 | 0.6 | -1.2 | -0.3 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 30.8 | 33.7 | 30.7 | 23.1 | 18.1 | 35 | 12.4 | 20 | 13.9 | 8.8 | 6 | ||
| YoY Gr. Rt. % | - | 9.6% | -9.1% | -24.7% | -21.9% | 93.7% | -64.7% | 62.2% | -30.4% | -36.7% | - | ||
| Adj EPS ⓘ | 27.4 | 17.5 | 16.9 | 17.8 | 19.9 | 93.1 | 29.5 | 125.8 | -19.7 | 47.9 | 32.3 | ||
| YoY Gr. Rt. % | - | -36.2% | -3.5% | 5.3% | 12.1% | 367.7% | -68.3% | 325.8% | -115.6% | NA | - | ||
| BVPS (₹) ⓘ | 147.4 | 168.9 | 185.8 | 199.8 | 223.7 | 327.9 | 358.2 | 497 | 478 | 532.5 | 180.1 | ||
| Adj Net Profit ⓘ | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 2.3 | 0.7 | 3.1 | -0.5 | 1.2 | 1 | ||
| Cash Flow from Ops. ⓘ | -8.1 | 12.2 | 2.3 | 6.8 | -6.5 | 1.5 | -3.8 | 3.8 | 10.3 | 3.5 | - | ||
| Debt/CF from Ops. ⓘ | -2 | 0.4 | 1.5 | 0 | -0.4 | 1.6 | -1.6 | 0.7 | 0 | 0 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | -13% | -13.4% | -10.6% | -36.7% | ||||||||
| Adj EPS ⓘ | 6.4% | 19.2% | 17.5% | NA | ||||||||
| BVPS ⓘ | 15.3 | 18.9 | 14.1 | 11.4 | ||||||||
| Share Price | - | - | - | - | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | 20.9 | 11.1 | 9.5 | 9.2 | 9.4 | 33.8 | 8.6 | 29.4 | -4 | 9.5 | 9.1 | |
| Op. Profit Mgn % ⓘ | 8.6 | 4 | 4.1 | 4.8 | 5.5 | 10.9 | 13.4 | 22.6 | -2.7 | 15.2 | 25.7 | |
| Net Profit Mgn % ⓘ | 2.2 | 1.3 | 1.4 | 1.9 | 2.7 | 6.5 | 5.9 | 15.4 | -3.5 | 13.3 | 13.9 | |
| Debt to Equity ⓘ | 4.5 | 1.2 | 0.8 | 0 | 0.5 | 0.3 | 0.7 | 0.2 | 0 | 0 | 0 | |
| Working Cap Days ⓘ | 148 | 137 | 75 | 49 | 93 | 91 | 342 | 261 | 234 | 73 | 0 | |
| Cash Conv. Cycle ⓘ | 138 | 121 | 59 | 18 | 16 | 52 | 298 | 228 | 198 | 34 | 0 | |
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Net Profit has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 32.3 | - |
| TTM Sales (₹ Cr.) | 5.6 | - |
| BVPS (₹.) ⓘ | 180.1 | - |
| Reserves (₹ Cr.) ⓘ | 4 | - |
| P/BV ⓘ | 0.10 | - |
| PE ⓘ | 0.54 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 17.40 / 17.40 |
| All Time Low / High (₹) | 10.60 / 19.90 |
| Market Cap (₹ Cr.) | 0.4 |
| Equity (₹ Cr.) | 0.2 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 37.3 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Triochem Products Ltd, incorporated in 1972 and having its registered office address at Sambava Chambers,4th Floor,Sir P M Road Fort Mumbai,Maharashtra-400001, is in the Pharmaceuticals & Drugs business.
The company offers contract manufacturing services to pharmaceutical companies located outside India. Alendronate sodium, iodinated glycerol, dinitro ortho toluamide, primidone, guinapyramine salts.
